(Q42914387)

11 November 2017

High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile (English)

1 reference

11 November 2017

R Jorde

1

1 reference

11 November 2017

Y Figenschau

2

1 reference

11 November 2017

M Hutchinson

3

1 reference

11 November 2017

N Emaus

4

1 reference

11 November 2017

G Grimnes

5

1 reference

11 November 2017

8 September 2010

1 reference

European Journal of Clinical Nutrition

11 November 2017

1 reference

11 November 2017

64

1 reference

11 November 2017

12

1 reference

11 November 2017

1457-1464

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2010.176

11 November 2017

0 references

cites work

Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

25-hydroxyvitamin D levels and the risk of mortality in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Vitamin D and mortality in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Serum 25-hydroxyvitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Effect of vitamin D on blood pressure: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Overview of general physiologic features and functions of vitamin D.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso Study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Regulation of adiposity by dietary calcium.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.176

7 January 2021

Identifiers

DOI

10.1038/EJCN.2010.176

1 reference

Dimensions Publication ID

11 November 2017

0 references

1 reference